WallStreetZenWallStreetZen

How to Buy Akebia Therapeutics Stock

Akebia Therapeutics Inc

Akebia Therapeutics, Inc. , a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.

Akebia Therapeutics stock last closed at $1.10, up 0.92% from the previous day, and has decreased 23.08% in one year. It has underperformed other stocks in the Biotechnology industry by 0.01 percentage points. Akebia Therapeutics stock is currently +41.03% from its 52-week low of $0.78, and -55.65% from its 52-week high of $2.48.

As of May 24, 2024, there are 209.6M shares of AKBA outstanding. The market capitalization of AKBA is $230.56M. In the last 24 hours, 1.59M AKBA shares were traded.

How to Buy Akebia Therapeutics Stock

Not sure how to invest in Akebia Therapeutics stock? Here's how.
  1. Decide where to buy Akebia Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you figure out where to buy Akebia Therapeutics stock.
  2. Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
  3. Deposit funds into your investment account: Select your method of payment and add your details.
  4. Evaluate Akebia Therapeutics stock: The Akebia Therapeutics ticker symbol is AKBA. Is Akebia Therapeutics stock a good investment? Should you buy shares of AKBA? How do AKBA's underlying business fundamentals look? Do top analysts think Akebia Therapeutics is a good buy? Why has AKBA's stock price moved recently? (Hint: Our stock market research website can help you evaluate if AKBA is a good stock to buy).
  5. Make your AKBA buy order: Decide if you will purchase AKBA shares at the current market price or use a limit order to purchase AKBA shares at a particular price.
  6. Keep tabs on your AKBA position: Create a watchlist to keep tabs on your investment in Akebia Therapeutics shares.

Step 1: Decide where to buy Akebia Therapeutics stock

You will need an online brokerage account in order to access the NASDAQ market and buy AKBA stock.

A brokerage account is an investment account that enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

In our opinion, eToro is the best brokerage. Here's why:

  • You can invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
  • Access to global markets: From Technology to Energy, New York to Tokyo — you can fill your portfolio with stocks from the world's top exchanges.
  • Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your purchase of stock by creating an account with eToro today.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create your brokerage account

Now that you've picked the best brokerage, the next step is to fill out some personal details so you are able to buy AKBA stock today.

How to Start a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal info to start your new brokerage account.
  1. Send your information by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your investment account

Now that you've opened your account on the best beginner stock app, you need to deposit funds:

Watch the video below if you need help transferring funds into your new investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Akebia Therapeutics stock

Once you have chosen the best place to buy Akebia Therapeutics stock, it's critical to research their stock before you buy, so you truly comprehend the risk and opportunity.

Overview of key AKBA info

AKBA Price
$1.10
1w %
-4.35%
1y %
-23.08%
5y %
-79.01%
P/E
-4.78x
P/B
-8.46x
P/S
1.2x
PEG
N/A
Revenue
$187.23M
Earnings
-$43.03M
Fore. Rev. Growth
4.83%
Fore. Earn. Growth
N/A
Market Cap
$230.56M
Next Earnings
Jun 5, 2024
Next Dividend
N/A

AKBA Zen Score

WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis.

You can see all of the due diligence checks on AKBA's stock page.

Is AKBA stock undervalued or overvalued?

Investors use a variety of different financial metrics, analyses, models, and charts to gauge AKBA's true value.

You can do additional valuation analysis on AKBA's stock here.

AKBA Financial Health Overview

Pros:

  • AKBA has cash burn of 25278000. It has sufficient cash and short-term investments to cover this for at least one year.
  • AKBA has $41.96M in cash and short term investments. This is sufficient to cover its annual cash burn of $25.28M.
  • There are more short-term assets than short-term liabilities on the AKBA balance sheet.

Cons:

  • There are more long-term liabilities than short-term assets on the AKBA balance sheet.
  • AKBA debt to equity ratio of -9.27 is negative.
  • AKBA profit margin has gone down from -21.3% to -23% in the past year.
  • Total AKBA debt is still negative.

Is AKBA stock a Buy, Hold, or Sell, according to Wall Street analysts?

Out of 2 Wall Street analysts who give ratings on AKBA, the consensus analyst rating on AKBA is a Strong Buy

Please note that analyst forecasts are not stock recommendations, nor are they investment advice.

You can dive deeper into what analysts are saying on the Akebia Therapeutics stock forecast page.

AKBA Technicals

SMA10
1.16
SMA20
1.24
SMA50
1.48
SMA100
1.5
SMA200
1.3
MACD
-0.09
MACD Signal
-0.08
MACD Histogram
-0.01
RSI
34.24
Stochastic %K
12.58
Stochastic %D
15.09
StochRSI %K
2.64
StochRSI %D
2.96

AKBA Revenue

Last year, AKBA revenue was $187.23M. Over the last 5 year, AKBA's revenue has grown by -4.4% per year. This was slower than the Biotechnology industry average of 32.14%.

You can research AKBA's earnings and revenue performance here.

What are AKBA insiders up to?

In the last 12 months, insiders at AKBA have sold more shares than they have bought.

Michel Dahan, SVP Chief Operating Officer of AKBA, was the latest AKBA insider to sell. They sold $43,898.40 worth of AKBA shares on May 13, 2024.

Dig into more about who owns AKBA stock here.

Can I get consistent income from AKBA stock?

No, Akebia Therapeutics doesn't provide an income stream by paying out dividends.

Get opinions from other investors

One of the major reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to see what other community members have to say.

Step 5: Make your AKBA buy order

You have two main options:

  • Market order: A market order is an order to buy or sell a stock at the best available price.
    Market orders are generally fine for most investors.
  • Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
    If you want to be certain you're buying or selling at an exact price, place a limit order.

Click the Open Trade button and eToro will execute the order.

If you need more assistance buying stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Keep tabs on your AKBA position

Now that you own some shares in AKBA, you'll want to stay up-to-date on your shares.

Put AKBA on a watchlist to get notified of important updates regarding your AKBA stock.

AKBA Feed

How to Buy Stock in Akebia Therapeutics

To reiterate, here are the 6 steps to buy stock in Akebia Therapeutics:

  1. Decide where to buy Akebia Therapeutics stock
  2. Create your brokerage account
  3. Deposit funds into your investment account
  4. Evaluate Akebia Therapeutics stock
  5. Make your AKBA buy order
  6. Keep tabs on your AKBA position

If you require a brokerage, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to get notifications regarding your new investment in Akebia Therapeutics, create a watchlist on WallStreetZen today.

NASDAQ: AKBA
$1.10+0.01 (+0.92%)
Updated May 24, 2024
Open eToro Account
NASDAQ: AKBA
$1.10+0.01 (+0.92%)
Updated May 24, 2024
Open eToro Account

FAQ

How much does it cost to buy one Akebia Therapeutics share?

As of May 24, 2024, it costs $1.10 to buy one share of Akebia Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.55, you can buy 0.5 shares of AKBA.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Akebia Therapeutics stock?

According to 2 Wall Street analysts who monitor Akebia Therapeutics, their consensus recommendation is to buy Akebia Therapeutics stock.

What is the best way to buy Akebia Therapeutics stock?

One way to place an order for Akebia Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.